findmyKOL
Clinical trialNCT00429039TerminatedPhase 2Interventional

A Study to Accelerate Immune System Recovery Following Stem Cell Transplantation

SponsorSidney Kimmel Comprehensive Cancer Center at Thomas Jefferson UniversityEnrollment21ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • Neal Flomenberg, M.D.

    Thomas Jefferson University, Department of Medical Oncology

    Principal Investigator

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Thomas Jefferson University Hospital

    Philadelphia, Pennsylvania, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Sept 2000
Primary completion
31 Oct 2007
Completion
31 Aug 2009
Last update posted
21 Oct 2016
Registered enrollment
21
Registry id
NCT00429039

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.